Intravacc Awarded US$14.6 Million NIH/NIAID Contract to Develop Intranasal Gonorrhea Vaccine - PR Newswire
/PRNewswire/ -- Intravacc, a world leader in translational research and development of preventive and therapeutic vaccines, today announced that it has been...
- Gonorrhea is on the WHO high-priority list of antimicrobial resistant bacteria
- World's first intranasal prophylactic gonorrhea vaccine candidate
- Mucosal vaccine platforms prov… [+5250 chars]
Read More
Other Stories in Health
- Why Princess Diana never wore heels while she was married to Charles
- Review: The Only One Left
- Review: Behind Closed Doors
- Review: Broken Country
- UQ researchers move closer to developing topical cream for skin cancers in transplant patients
- Ancient footprints reveal two hominin species coexisting 1.5 million years ago
- How to manifest anything you want? Neuroscientist's 6 steps to manifest right
- Review: Lies He Told Me
- Mandatory calorie labels boost awareness but fail to reduce intake
.png)
